DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/tr5tkv/chinese_markets) has announced the addition of the "Chinese Markets for Asthma Treatment Drugs" report to their offering.
China's demand for asthma treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
Beijing SL Pharmaceutical Co., Ltd
Yangtze River Pharmaceutical Group
Hangzhou Aoyipollen Pharmaceutical Co., Ltd.
Zhuhai Union Pharmaceutical Co., Ltd
Shandong Qilu Pharmaceutical Co., Ltd
Chengdu Minyi Pharmaceutical Co., Ltd
Henan Jiaozuo KL Pharmaceutical Co., Ltd
Changzhou Siyao Pharmaceutical Co., Ltd
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. ASTHMA TREATMENT DRUGS INDUSTRY ASSESSMENTS
IV. ASTHMA TREATMENT DRUGS OUTPUT AND DEMAND
V. ASTHMA TREATMENT DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
VII. ASTHMA TREATMENT DRUGS PRODUCER DIRECTORY
LIST OF TABLES
LIST OF CHARTS
For more information visit http://www.researchandmarkets.com/research/tr5tkv/chinese_markets
Source: Research and Markets